# Pebblebrook Hotel Trust: financial statements, quarterly

PEB · NYSE · CIK 1474098 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/peb.md) · [Financials](/companies/peb/financials.md) · [Filings](/companies/peb/filings.md) · [Insiders](/companies/peb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/peb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [334 d](/filings/0001474098-26-000015.md) | [314](/filings/0001474098-25-000070.md) | [397](/filings/0001474098-25-000119.md) | [405](/filings/0001474098-25-000138.md) | [338 d](/filings/0001474098-26-000015.md) | [320](/filings/0001474098-26-000039.md) | [408](/filings/0001474098-26-000055.md) | [399](/filings/0001474098-26-000072.md) | [349 d](/filings/0001474098-26-000015.md) | [346](/filings/0001474098-26-000039.md) | [407](/filings/0001474098-26-000055.md) | [403](/filings/0001474098-26-000072.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(16.2) d](/filings/0001474098-26-000015.md) | [(1.4)](/filings/0001474098-25-000070.md) | [61.0](/filings/0001474098-25-000119.md) | [47.1](/filings/0001474098-25-000138.md) | [(22.6) d](/filings/0001474098-26-000015.md) | [(7.2)](/filings/0001474098-26-000039.md) | [52.4](/filings/0001474098-26-000055.md) | [(10.2)](/filings/0001474098-26-000072.md) | [8.9 d](/filings/0001474098-26-000015.md) | [8.1](/filings/0001474098-26-000039.md) | [57.2](/filings/0001474098-26-000055.md) | [(27.6)](/filings/0001474098-26-000072.md) |
| Interest expense | $m | [27.7 d](/filings/0001474098-24-000040.md) | [26.4](/filings/0001474098-24-000078.md) | [27.9](/filings/0001474098-25-000119.md) | [27.9](/filings/0001474098-25-000138.md) | [30.1 d](/filings/0001474098-26-000015.md) | [27.1](/filings/0001474098-26-000039.md) | [27.3](/filings/0001474098-26-000055.md) | [20.2](/filings/0001474098-26-000072.md) | [28.7 d](/filings/0001474098-26-000015.md) | [26.3](/filings/0001474098-26-000039.md) | [26.1](/filings/0001474098-26-000055.md) | [25.9](/filings/0001474098-26-000072.md) |
| Income tax | $m | [(0.2) d](/filings/0001474098-26-000015.md) | [0.0](/filings/0001474098-25-000070.md) | [1.0](/filings/0001474098-25-000119.md) | [(25.2)](/filings/0001474098-25-000138.md) | [(1.5) d](/filings/0001474098-26-000015.md) | [(3.2)](/filings/0001474098-26-000039.md) | [7.8](/filings/0001474098-26-000055.md) | [3.0](/filings/0001474098-26-000072.md) | [(1.4) d](/filings/0001474098-26-000015.md) | [(0.0)](/filings/0001474098-26-000039.md) | [7.7](/filings/0001474098-26-000055.md) | [3.2](/filings/0001474098-26-000072.md) |
| Net income | $m | [(42.7) d](/filings/0001474098-26-000015.md) | [(28.4)](/filings/0001474098-25-000070.md) | [30.9](/filings/0001474098-25-000119.md) | [43.7](/filings/0001474098-25-000138.md) | [(50.5) d](/filings/0001474098-26-000015.md) | [(32.9)](/filings/0001474098-26-000039.md) | [18.1](/filings/0001474098-26-000055.md) | [(33.1)](/filings/0001474098-26-000072.md) | [(17.9) d](/filings/0001474098-26-000015.md) | [(19.3)](/filings/0001474098-26-000039.md) | [23.6](/filings/0001474098-26-000055.md) | [(55.0)](/filings/0001474098-26-000072.md) |
| Diluted EPS | $ per share | not reported | [(0.32)](/filings/0001474098-25-000070.md) | [0.16](/filings/0001474098-25-000119.md) | [0.24](/filings/0001474098-25-000138.md) | not reported | [(0.37)](/filings/0001474098-26-000039.md) | [0.06](/filings/0001474098-26-000055.md) | [(0.37)](/filings/0001474098-26-000072.md) | not reported | [(0.26)](/filings/0001474098-26-000039.md) | [0.17](/filings/0001474098-26-000055.md) | [(0.56)](/filings/0001474098-26-000072.md) |
| Basic EPS | $ per share | not reported | [(0.32)](/filings/0001474098-25-000070.md) | [0.17](/filings/0001474098-25-000119.md) | [0.27](/filings/0001474098-25-000138.md) | not reported | [(0.37)](/filings/0001474098-26-000039.md) | [0.06](/filings/0001474098-26-000055.md) | [(0.37)](/filings/0001474098-26-000072.md) | not reported | [(0.26)](/filings/0001474098-26-000039.md) | [0.18](/filings/0001474098-26-000055.md) | [(0.56)](/filings/0001474098-26-000072.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [184](/filings/0001474098-25-000039.md) | [56.7](/filings/0001474098-24-000078.md) | [102](/filings/0001474098-24-000101.md) | [134](/filings/0001474098-24-000135.md) | [207](/filings/0001474098-26-000015.md) | [208](/filings/0001474098-25-000070.md) | [256](/filings/0001474098-25-000119.md) | [223](/filings/0001474098-25-000138.md) | [184](/filings/0001474098-26-000072.md) | [196](/filings/0001474098-26-000039.md) | [261](/filings/0001474098-26-000055.md) | [288](/filings/0001474098-26-000072.md) |
| Total assets | $m | [5,825](/filings/0001474098-25-000039.md) | [5,698](/filings/0001474098-24-000078.md) | [5,704](/filings/0001474098-24-000101.md) | [5,723](/filings/0001474098-24-000135.md) | [5,693](/filings/0001474098-26-000015.md) | [5,651](/filings/0001474098-25-000070.md) | [5,653](/filings/0001474098-25-000119.md) | [5,554](/filings/0001474098-25-000138.md) | [5,348](/filings/0001474098-26-000072.md) | [5,304](/filings/0001474098-26-000039.md) | [5,282](/filings/0001474098-26-000055.md) | [5,204](/filings/0001474098-26-000072.md) |
| Total liabilities | $m | [2,975](/filings/0001474098-25-000039.md) | [2,884](/filings/0001474098-24-000078.md) | [2,870](/filings/0001474098-24-000101.md) | [2,881](/filings/0001474098-24-000135.md) | [2,905](/filings/0001474098-26-000015.md) | [2,924](/filings/0001474098-25-000070.md) | [2,922](/filings/0001474098-25-000119.md) | [2,947](/filings/0001474098-25-000138.md) | [2,785](/filings/0001474098-26-000072.md) | [2,773](/filings/0001474098-26-000039.md) | [2,768](/filings/0001474098-26-000055.md) | [2,779](/filings/0001474098-26-000072.md) |
| Long-term debt | $m | [2,320](/filings/0001474098-25-000039.md) | [2,207](/filings/0001474098-24-000078.md) | [2,207](/filings/0001474098-24-000101.md) | [2,208](/filings/0001474098-24-000135.md) | [2,247](/filings/0001474098-26-000015.md) | [2,247](/filings/0001474098-25-000070.md) | [2,248](/filings/0001474098-25-000119.md) | [2,239](/filings/0001474098-25-000138.md) | [2,124](/filings/0001474098-26-000072.md) | [2,079](/filings/0001474098-26-000039.md) | [2,081](/filings/0001474098-26-000055.md) | [2,082](/filings/0001474098-26-000072.md) |
| Shareholders' equity | $m | [2,764](/filings/0001474098-25-000039.md) | [2,726](/filings/0001474098-24-000078.md) | [2,746](/filings/0001474098-24-000101.md) | [2,752](/filings/0001474098-24-000135.md) | [2,697](/filings/0001474098-26-000015.md) | [2,635](/filings/0001474098-25-000070.md) | [2,639](/filings/0001474098-25-000119.md) | [2,514](/filings/0001474098-25-000138.md) | [2,469](/filings/0001474098-26-000072.md) | [2,437](/filings/0001474098-26-000039.md) | [2,418](/filings/0001474098-26-000055.md) | [2,330](/filings/0001474098-26-000072.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [33.9 d](/filings/0001474098-26-000015.md) | [46.0](/filings/0001474098-25-000070.md) | [83.7 d](/filings/0001474098-25-000119.md) | [76.1 d](/filings/0001474098-25-000138.md) | [69.3 d](/filings/0001474098-26-000015.md) | [50.3](/filings/0001474098-26-000039.md) | [90.5 d](/filings/0001474098-26-000055.md) | [77.6 d](/filings/0001474098-26-000072.md) | [31.3 d](/filings/0001474098-26-000015.md) | [84.1](/filings/0001474098-26-000039.md) | [86.3 d](/filings/0001474098-26-000055.md) | [84.9 d](/filings/0001474098-26-000072.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [1.2 d](/filings/0001474098-26-000015.md) | [1.2](/filings/0001474098-25-000070.md) | [1.2 d](/filings/0001474098-25-000119.md) | [1.2 d](/filings/0001474098-25-000138.md) | [1.2 d](/filings/0001474098-26-000015.md) | [1.2](/filings/0001474098-26-000039.md) | [1.2 d](/filings/0001474098-26-000055.md) | [1.2 d](/filings/0001474098-26-000072.md) | [1.2 d](/filings/0001474098-26-000015.md) | [1.1](/filings/0001474098-26-000039.md) | [1.1 d](/filings/0001474098-26-000055.md) | [1.1 d](/filings/0001474098-26-000072.md) |
| Share repurchases | $m | [0.0 d](/filings/0001474098-26-000015.md) | [6.9](/filings/0001474098-25-000070.md) | [0.0 d](/filings/0001474098-25-000119.md) | [10.0 d](/filings/0001474098-25-000138.md) | [0.0 d](/filings/0001474098-26-000015.md) | [14.6](/filings/0001474098-26-000039.md) | [1.0 d](/filings/0001474098-26-000055.md) | [50.0 d](/filings/0001474098-26-000072.md) | [7.0 d](/filings/0001474098-26-000015.md) | [5.9](/filings/0001474098-26-000039.md) | [8.0 d](/filings/0001474098-26-000055.md) | [20.9 d](/filings/0001474098-26-000072.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [125](/filings/0001474098-24-000078.md) | [151](/filings/0001474098-24-000101.md) | [120](/filings/0001474098-24-000135.md) | [120](/filings/0001474098-25-000070.md) | [150](/filings/0001474098-25-000119.md) | [149](/filings/0001474098-25-000138.md) | [119](/filings/0001474098-26-000039.md) | [118](/filings/0001474098-26-000055.md) | [118](/filings/0001474098-26-000072.md) | [113](/filings/0001474098-26-000039.md) | [127](/filings/0001474098-26-000055.md) | [112](/filings/0001474098-26-000072.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 111,694,079 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0001474098-26-000072.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:33 ET. No prices; not investment advice.